Eman Ayman Nada |  Public Health Analytics | Best Researcher Award

Dr. Eman Ayman Nada |  Public Health Analytics | Best Researcher Award

Mnistry of Health, Damietta | Egypt

Dr. Eman Ayman Nada is a pharmacist-researcher who earned her Bachelor’s degree in Pharmaceutical Sciences at the Tanta University (2017–2022), graduating with a “Very Good” grade. She currently serves as a hospital pharmacist at Kafr Saad Central Hospital in Damietta, Egypt, and as a researcher with the Medical Research Group of Egypt (MRGE) in Arlington, USA. In her research role she has led systematic reviews and meta-analyses (including as first or corresponding author), performing data analysis with RevMan and SPSS. Her education and internships have included clinical research training (via Negida Academy) and GCP certification (viaMedical Agency for Research and Statistics in London). Her research interests span clinical pharmacy, systematic reviews and meta-analysis, pharmacoepidemiology, drug safety and pharmacovigilance, and the intersection of data-analysis / machine-learning with public-health outcomes. She has also served in student-research leadership roles, coordinating training for hundreds of students in scientific research methodology. Looking ahead, she aims to further publish high-impact evidence-based medicine studies, mentor emerging researchers, and contribute to improved pharmaceutical care through rigorous clinical research.

Profiles : Orcid | Scopus

Featured Publications

1️⃣ Nada, E. A., Abu Kaddorah, M. E., El Jamal, M., Hamad, A., & Mansour, F. R. (2025). Eggshell waste as a sustainable resource for nanoparticle preparation; synthesis, characterization and applications. Environmental Nanotechnology, Monitoring & Management.

2️⃣ Varghese, C., Peters, L., Gaborit, L., Xu, W., Kalyanasundaram, K., Basam, A., Park, M., Wells, C., McLean, K. A., Schamberg, G., et al. (2025). Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model. npj Digital Medicine.

3️⃣ Zaazouee, M. S., Nada, E. A., Al-kafarna, M., Shaheen, A., Ramu, S. K., Hafez, A. H., Matar, S. G., Assar, A., Elshennawy, M., Abu El-Enien, H., et al. (2025). A multinational cross-sectional study on the prevalence and predictors of long COVID across 33 countries. Scientific Reports.

4️⃣ Abdelghany, A., Qutob, I. A., Abdel Azim, A., Assem, M., Gad, M., Shawkat, A., Gamal, A., & Nada, E. A. (2025). Perioperative and oncological outcomes of laparoscopic versus open pancreaticoduodenectomy: A meta-analysis of randomized controlled trials. Annals of Oncology.

5️⃣ Chukr, M., Mohamady, A. O., Abdallh, F., Farrag, D. A., Nada, E. A., Qutob, I. A., & Elsayed, M. M. (2025). Knowledge, Attitudes, and Practices of Blood Donation Among Medical Students: A Systematic Review Across Nine Countries. Preprint.

 

Alexia Iasonos | Algorithm Development | Best Researcher Award

Dr. Alexia Iasonos | Algorithm Development | Best Researcher Award

Memorial Sloan-Kettering Cancer Center | United States

Dr. Alexia E. Iasonos is a recognized expert in biostatistics, currently a Member at Memorial Sloan Kettering Cancer Center where she serves as Director of Clinical Research Development. She earned her B.S. in Mathematics & Statistics from the University of Cyprus (1992-96), followed by an M.S. in Biometry & Statistics and a Ph.D. in Biometry & Statistics from SUNY Albany (awarded in 1998 and 2002 respectively). Her professional trajectory includes roles in academic statistics, pharmaceutical industry, and extensive hospital-affiliated clinical trial biostatistics. Her methodological research focuses on design and analysis of clinical trials, especially Bayesian adaptive Phase I and II designs, dose-finding methods, dose-expansion cohort development, predictive modeling and nomograms, biomarker evaluation and endpoints, particularly in gynecologic oncology. Her work has been instrumental in improving early drug development processes. According to AD Scientific Index, her h-index is 52, with over 10,779 total citations. She is an elected Fellow of the Society of Clinical Trials, deputy editor of Journal of Clinical Oncology, member/chair in several protocol and monitoring committees. Among her awards are those tied to leadership in early-phase trial methodology and contributions to cancer biostatistics. In conclusion, Dr. Iasonos continues to make high impact contributions in biostatistics and oncology by combining rigorous methodology with translational collaboration.

Profile : Scopus

Featured Publications

Iasonos, A. (2024). Evaluation of early phase dose finding algorithms in heterogeneous populations. Journal of Statistical Planning and Inference.

Iasonos, A. (2023). Controlled amplification in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2022). Stopping rules for phase I clinical trials with dose expansion cohorts. Statistical Methods in Medical Research.

Iasonos, A. (2021). Controlled backfill in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2021). Phase I clinical trials in adoptive T-cell therapies. Journal of the Royal Statistical Society: Series C (Applied Statistics).